Efficacy and safety of daily use of tadalafil in treatment of patients with premature ejaculation: A randomised placebo‐controlled clinical trial
This study showed that there were no statistically significant differences between patients in the placebo and tadalafil groups regarding the mean values of the seven questions and total scores of the AIPE questionnaire before treatment (p value >.05). The mean values of the seven questions and total scores of AIPE questionnaire in the tadalafil group were significantly higher than the placebo group after treatment (p value = .001). This study concluded that once‐daily use of 5 mg tadalafil for 6 weeks was effective and well tolerated in the treatment of patients with PE.
Source: Andrologia - Category: Urology & Nephrology Authors: M. Abu El ‐Hamd Tags: ORIGINAL ARTICLE Source Type: research
More News: Cialis | Clinical Trials | Eyes | Middle East Health | Premature Ejaculation | Statistics | Study | Urology & Nephrology